The Role of D-3-Phosphoglycerate Dehydrogenase (PHGDH) in Chemoresistance in Ovarian Cancer: Molecular Insights and Therapeutic Potential
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27219535 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jesús Omar Velázquez-Moreno und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Guerrero, Av. Lázaro Cárdenas S/N Sede Sur, El…. Hauptthemen laut MEDLINE: Phosphoglycerate Dehydrogenase, Ovarian Neoplasms, Drug Resistance, Neoplasm. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación.
Abstract (Originalsprache)
Ovarian cancer (OC) is often diagnosed at advanced stages, and resistance to platinum-based chemotherapy remains one of the leading causes of treatment failure. This resistance is sustained in part by metabolic plasticity, particularly through the de novo serine synthesis pathway (SSP), orchestrated by D-3-phosphoglycerate dehydrogenase (PHGDH), which diverts glycolytic carbon toward serine, glycine, and one-carbon (1C) units that fuel nucleotide biosynthesis, epigenetic regulation, and redox homeostasis. Elevated PHGDH expression in OC is associated with advanced International Federation of Gynecology and Obstetrics (FIGO) stage and poorer overall survival; conversely, a subset of tumors downregulates PHGDH at relapse and shifts toward NAD+-dependent pathways that sustain poly(ADP-ribose) polymerase (PARP) activity and DNA repair, creating a distinct therapeutic vulnerability. Rather than a contradiction, this bidirectional behavior reflects the metabolic plasticity through which OC adapts to treatment pressure. Therefore, this review analyzes the context-dependent role of PHGDH in OC, the mechanistic basis of divergent associations with therapy resistance, and the current status of pharmacological inhibitors. Preclinical evidence indicates that PHGDH inhibition with CBR-5884 increases oxidative stress, reduces stemness, and restores platinum sensitivity in PHGDH-high models. We further identify the relationship between PHGDH and radiotherapy response as an unexplored question in OC, despite evidence of SSP-dependent radioresistance in other tumor types. Together, these observations position PHGDH as an actionable, but biomarker-dependent, metabolic target in OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Guerrero, Av. Lázaro Cárdenas S/N Sede Sur, El Centenario, Chilpancingo 39090, Mexico.
- Clínica de Cáncer Hereditario-Instituto Nacional de Cancerología, Av. San Fernando 22, Belisario Domínguez Secc 16, Tlalpan, Ciudad de Mexico 14080, Mexico.
- Programa Investigadores por México-Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Av. Insurgentes Centro 1582, Crédito Constructor, Benito Juárez, Ciudad de Mexico 03940, Mexico.
ORCID-Profile: Jesús Omar Velázquez-Moreno, María de la Luz Mejía-Aguayo, Rodrigo Sosa-León, Marco Antonio Leyva-Vázquez, Olga Lilia Garibay-Cerdenares
Förderung
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
Zitieren
APA
Velázquez-Moreno, J. O., Mejía-Aguayo, M. L., Casarrubias-Jaimes, F. D. P., De la Fuente-Hernández, M. A., Apolonio-Sánchez, D. J., Sosa-León, R., Álvarez-Gómez, R. M., Leyva-Vázquez, M. A., Pedroza-Torres, A., & Garibay-Cerdenares, O. L. (2026). The Role of D-3-Phosphoglycerate Dehydrogenase (PHGDH) in Chemoresistance in Ovarian Cancer: Molecular Insights and Therapeutic Potential. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219535
Vancouver
Velázquez-Moreno JO, Mejía-Aguayo ML, Casarrubias-Jaimes FDP, De la Fuente-Hernández MA, Apolonio-Sánchez DJ, Sosa-León R, et al. The Role of D-3-Phosphoglycerate Dehydrogenase (PHGDH) in Chemoresistance in Ovarian Cancer: Molecular Insights and Therapeutic Potential. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219535
BibTeX
@article{VelzquezMoreno2026,
author = {Velázquez-Moreno, Jesús Omar and Mejía-Aguayo, María de la Luz and Casarrubias-Jaimes, Felix De Dios Padre and De la Fuente-Hernández, Marcela Angélica and Apolonio-Sánchez, Daniel de Jesús and Sosa-León, Rodrigo and Álvarez-Gómez, Rosa María and Leyva-Vázquez, Marco Antonio and Pedroza-Torres, Abraham and Garibay-Cerdenares, Olga Lilia},
title = {The Role of D-3-Phosphoglycerate Dehydrogenase (PHGDH) in Chemoresistance in Ovarian Cancer: Molecular Insights and Therapeutic Potential},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27219535}
}
EUVIMED